appeals for gip glp 1 Managing GLP-1/GIP side effects with diet and lifestyle GLP agonist + Dual GIP+GLP

Improvements in glycemic control were noted in both groups with increased vegetable intake

Semaglutide 2.4 mg (Wegovy): ~15% body weight loss at 68 weeks in clinical trials Tirzepatide 15 mg (Zepbound): ~21% body weight loss at 72 weeks in clinical trials Real-world data shows lower results: Cleveland Clinic research from 2025 found average weight loss of 7.7% with semaglutide and 12.4% with tirzepatide at one year in routine clinical practice

Chris Centeno summarized in this article a review of the total PRP studies for knee osteoarthritis, and quantified those with favorable results and unfavorable results

The inflammatory response induced by acute or chronic infection may initiate or accelerate early and subclinical processes underlying the early stages of PD

(Accessed December 10, 2025)